CPNE1 and lung cancer: Here, our study newly reported an oncogenetic role of miR‐335 in lung adenocarcinoma, by which miR‐335 enhances migratory and invasive abilities of lung cancer cells via targeting copine‐1 (CPNE1), an NF‐κB signaling suppressor.